CHCF invests in SIRUM, a committed group of social entrepreneurs who run an application that matches safety-net clinics in need of drugs with medical facilities that have them to donate.

This issue brief provides an overview of the Medi-Cal outpatient prescription drug benefit program, summarizes the impact of Medicare Part D on drug utilization and spending by Medi-Cal beneficiaries, and considers Medi-Cal's approaches to managing drug costs.

This briefing discused e-prescribing in California; its effects on efficiency, costs, and patient safety; and issues related to "eRx" adoption.

This presentation examines key elements of the Medicare drug benefit to provide a portrait of the program's implementation in California and to highlight important changes for 2009.

This fact sheet examines the variations among the Medicare drug benefit plans available to low-income beneficiaries in 2008, including premium subsidies, availability of brand-name drugs versus generics, and coverage for the 100 most commonly used drugs.

This fact sheet provides a first look at changes to Medicare Part D offerings in California for 2008. It examines changes in the number of participating plans, benefits, premiums, and cost sharing.